The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Expansion In Market Value Is Forecasted For The Antiparasitic Drugs Market Between 2026 And 2030?
The antiparasitic drugs market has experienced robust growth in recent years. It is anticipated to expand from $25.58 billion in 2025 to $27.18 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.2%. This historical growth can be attributed to factors such as the increasing occurrence of parasitic diseases, restricted access to modern antiparasitic drugs in developing regions, a customary reliance on monotherapy drugs, rising demand for veterinary care, and insufficient public awareness about preventive measures.
The antiparasitic drugs market is projected to experience substantial expansion over the coming years, reaching $36.13 billion by 2030, driven by a compound annual growth rate (CAGR) of 7.4%. This anticipated growth is largely due to factors such as increased adoption of combination therapies, innovations in precision medicine for parasitic infections, a heightened emphasis on animal well-being and livestock safeguarding, the broadening of emerging markets, and the creation of new delivery methods for antiparasitic medications. Key trends expected during this period involve a rise in parasitic infection occurrences, the formulation of combination antiparasitic drugs, an increase in animal healthcare uses, a preference shift towards oral and injectable treatments, and the introduction of innovative antiparasitic agents.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12927&type=smp
Which Important Drivers Are Guiding The Antiparasitic Drugs Market Growth?
The future expansion of the antiparasitic drugs market is anticipated to be driven by the rising occurrence of vector-borne diseases. These diseases are defined as infectious conditions spread to people or animals via the bites of arthropods, mainly insects such as mosquitoes, ticks, and flies. Examples of vector-borne illnesses include malaria, dengue, and yellow fever. Antiparasitic medications are crucial for halting the transmission of vector-borne diseases by targeting and eradicating the causative parasites. Several antiparasitic drugs, such as chloroquine, doxycycline, and atovaquone-proguanil, are frequently employed in malaria treatment. For instance, the Centers for Disease Control and Prevention, a US Government agency, reported in June 2024 that from January to June 2024, the Americas experienced over 9.7 million dengue cases, which was more than twice the 4.6 million cases documented in 2023. Within the United States, Puerto Rico recorded 1,498 dengue cases, with an additional 745 cases found among U.S. travelers coming back from regions where the disease is prevalent. Consequently, the rising occurrence of vector-borne diseases fuels the expansion of the antiparasitic drugs market.
How Is The Antiparasitic Drugs Market Segmented Across Different Segment Categories?
The antiparasitic drugs market covered in this report is segmented –
1) By Product Type: Anthelmintics, Antiprotozoals, Ectoparasiticide, Other Products
2) By Treatment: Avermectins, Bezimidazoles, Pyrimidines, Imidazolesthiazoles
3) By Route of Administration: Oral, Injectable, Topical
4) By End User: Hospitals, Homecare, Specialty Clinics, Other End Users
Subsegments:
1) By Anthelmintics: Benzimidazoles, Ivermectin, Pyrantel Pamoate, Praziquantel
2) By Antiprotozoals: Metronidazole, Tinidazole, Nitazoxanide, Pentamidine
3) By Ectoparasiticides: Permethrin, Malathion, Fipronil
4) By Other Products: Combination Antiparasitic Drugs, Novel Antiparasitic Agents
Which Trends Are Contributing To Changes In The Antiparasitic Drugs Market?
Leading companies in the antiparasitic drugs market are concentrating on developing innovative offerings, such as chewable veterinary products, to enhance ease of administration and improve pet adherence. Chewable veterinary products are flavored, simple-to-administer tablets or treats designed to deliver medication to animals. They improve pet cooperation by making treatment more palatable and less stressful. For example, in April 2024, C.H. Boehringer Sohn AG and Co. KG, a Germany-based pharmaceutical firm, introduced NexGard Spectra to deliver comprehensive parasite management. NexGard SPECTRA is a soft, flavorful chew that provides extensive internal and external parasite control for dogs, effectively targeting fleas, ticks, heartworms, and various intestinal worms with a single monthly dose. It demonstrates rapid action, eliminating fleas within four hours of administration and achieving over 99% effectiveness against multiple parasites shortly thereafter.
Which Organizations Play A Role In The Antiparasitic Drugs Market Landscape?
Major companies operating in the antiparasitic drugs market are Pfizer Inc., Johnson & Johnson, Cadila Pharmaceuticals, Merck & Co. Inc., Bayer AG, Novartis AG, Sanofi S.A., GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Boehringer Ingelheim Group, Zoetis Inc., Eisai Co. Ltd., Dr. Reddy’s Laboratories, Intas Pharmaceuticals Ltd., Alkem Laboratories Ltd., Ceva Santé Animale S.A., Elanco Animal Health Incorporated, Phibro Animal Health Corporation, Norbrook Laboratories Ltd., Mankind Pharma, Bimeda Inc., Indoco Remedies Ltd., ECO Animal Health, Lincoln Pharmaceuticals Ltd., Laboratorios Calier
Get The Full Antiparasitic Drugs Market Report:
https://www.thebusinessresearchcompany.com/report/antiparasitic-drugs-global-market-report
Which Region Leads The Antiparasitic Drugs Market In Terms Of Market Share?
North America was the largest region in the antiparasitic drugs market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the antiparasitic drugs market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Antiparasitic Drugs Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/report/antiparasitic-drugs-global-market-report
Browse Through More Reports Similar to the Global Antiparasitic Drugs Market 2026, By The Business Research Company
Antiparasitic Drugs Market Report 2026
https://www.thebusinessresearchcompany.com/report/antiparasitic-drugs-global-market-report
Antispasmodics Drugs Market Report 2026
https://www.thebusinessresearchcompany.com/report/antispasmodics-drugs-global-market-report
Anticholinergic Drugs Market Report 2026
https://www.thebusinessresearchcompany.com/report/anticholinergic-drugs-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model